In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Genome Therapeutics and Amgen conclude research agreement
Genome Therapeutics reaches milestone in asthma research
Human Genome Sciences announces license agreement with Amgen
Genome Therapeutics to transfer patents to Aventis
Genome Therapeutics attains milestone in antifungal alliance with Schering-Plough
BIOFOCUS ACHIEVES MILESTONE IN AMGEN COLLABORATION
Array BioPharma Receives Milestone Payment From Amgen
Genome attains second fungal infection milestone for Schering